PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+16.82%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.41B
AUM Growth
+$3.41B
(-8.1%)
Cap. Flow
-$544M
Cap. Flow
% of AUM
-15.97%
Top 10 Holdings %
Top 10 Hldgs %
33.11%
Holding
124
New
24
Increased
28
Reduced
22
Closed
33
Top Buys
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$93.1M |
| 2 |
McKesson
MCK
|
$72.1M |
| 3 |
ServiceNow
NOW
|
$65.6M |
| 4 |
DXC Technology
DXC
|
$60M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$59.2M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$125M |
| 2 |
Marvell Technology
MRVL
|
$120M |
| 3 |
Biogen
BIIB
|
$105M |
| 4 |
WFT
Weatherford International plc
WFT
|
$102M |
| 5 |
CSC
Computer Sciences
CSC
|
$98M |
Sector Composition
| 1 | Healthcare | 43.67% |
| 2 | Technology | 14.99% |
| 3 | Consumer Discretionary | 6.03% |
| 4 | Communication Services | 4.45% |
| 5 | Financials | 4.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
| $181M | 4.87% | 1,743,351 +897,958 | +106% | +$93.1M |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $154M | 4.15% | 2,745,842 +1,053,332 | +62% | +$59.2M |
|
3
Puma Biotechnology
PBYI
$254M
| $147M | 3.96% | 1,682,158 +616,802 | +58% | +$53.9M |
|
4
Elevance Health
ELV
$71.8B
| $104M | 2.81% | 555,316 +115,190 | +26% | +$21.7M |
|
5
Alibaba
BABA
$322B
| $99.1M | 2.67% | 703,046 -106,973 | -13% | -$15.1M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $91.9M | 2.47% | 1,748,040 +454,911 | +35% | +$23.9M |
|
7
Universal Health Services
UHS
$11.6B
| $91.1M | 2.45% | 746,051 +48,093 | +7% | +$5.87M |
|
8
GoDaddy
GDDY
$20.5B
| $89.4M | 2.41% | 2,107,643 +328,171 | +18% | +$13.9M |
|
9
Pacira BioSciences
PCRX
$1.2B
| $87.8M | 2.37% | 1,840,618 +213,341 | +13% | +$10.2M |
|
10
Microsoft
MSFT
$3.77T
| $81M | 2.18% | 1,175,303 +845,099 | +256% | +$58.3M |
|
11
Humana
HUM
$36.5B
| $80.9M | 2.18% | 336,307 -58,535 | -15% | -$14.1M |
|
12
Edwards Lifesciences
EW
$47.8B
| $72.7M | 1.96% | 614,811 +158,045 | +35% | +$18.7M |
|
|
13
McKesson
MCK
$85.4B
| $72.1M | 1.94% | +438,055 | New | +$72.1M |
|
14
Baxter International
BAX
$12.7B
| $71.5M | 1.93% | 1,180,582 +18,094 | +2% | +$1.1M |
|
|
MDCO
15
DELISTED
Medicines Co
MDCO
| $68.9M | 1.86% | 1,813,002 -37,633 | -2% | -$1.43M |
|
|
16
ServiceNow
NOW
$190B
| $65.6M | 1.77% | +618,736 | New | +$65.6M |
|
|
BPMC
17
DELISTED
Blueprint Medicines
BPMC
| $65.2M | 1.76% | 1,286,450 +234,438 | +22% | +$11.9M |
|
18
Cigna
CI
$80.3B
| $61M | 1.64% | 364,245 +69,649 | +24% | +$11.7M |
|
19
UnitedHealth
UNH
$281B
| $61M | 1.64% | 328,829 +15,431 | +5% | +$2.86M |
|
20
Molina Healthcare
MOH
$9.8B
| $60.9M | 1.64% | 880,402 +346,181 | +65% | +$23.9M |
|
|
21
DXC Technology
DXC
$2.59B
| $60M | 1.62% | +781,879 | New | +$60M |
|
22
Amazon
AMZN
$2.44T
| $58.5M | 1.58% | +60,412 | New | +$58.5M |
|
23
Abbott
ABT
$231B
| $53.6M | 1.44% | +1,102,781 | New | +$53.6M |
|
24
Visa
V
$683B
| $52.7M | 1.42% | 561,690 +275,675 | +96% | +$25.9M |
|
|
ACOR
25
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $51M | 1.37% | +2,588,157 | New | +$51M |
|